BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

IDNAvsTMEDETF Comparison

ETF 1

IDNA

iShares Genomics Immunology and Healthcare ETF

This fund is part of

BioTech & Genomics

-0.67%

Full IDNA fund page

VS

ETF 2

TMED

T. Rowe Price Health Care ETF

This fund is part of

US Health Care

-1.08%

Full TMED fund page

iShares Genomics Immunology and Healthcare ETF (IDNA) belongs to the BioTech & Genomics segment. T. Rowe Price Health Care ETF (TMED) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. IDNA is more expensive with a Total Expense Ratio (TER) of 0.47%, versus 0.44% for TMED. IDNA is up 14.46% year-to-date (YTD) with +$14M in YTD flows. TMED performs worse with 0.34% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of IDNA and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

IDNA vs TMED performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 04/24/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	IDNA TMED	+6.55%+6.09%	+1.85%-3.03%	+14.46%+0.34%	+46.26%n/a	+29.46%n/a	-35.24%n/a
Flows	IDNA TMED	+$8M-$41K	+$14M+$1M	+$14M+$3M	+$7M-	-$12M-	+$13M-

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	IDNA TMED	+24.19%+21.25%	+23.76%n/a	+24.04%n/a	+27.93%n/a
Max drawdown	IDNA TMED	-10.60%-9.96%	-10.60%n/a	-30.61%n/a	-68.19%n/a
Max drawdown duration	IDNA TMED	46d80d	46dn/a	279dn/a	1678dn/a

Trading data

Create an account to view trading data

Join for free

	IDNA	TMED
Last sale 4/27/2026 at 4:13 PM	$29.83	$29.85
Previous close 04/24/2026	$29.98	$29.79
Consolidated volume 04/24/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of March 31, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

TMED

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	IDNA	TMED
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 4/27/2026 at 4:13 PM

Live

Closed

	IDNA	TMED
Last price	$29.83	$29.85
1D performance	-0.50%	+0.19%
AuM	$163.33 M	$19.36 M
E/R	0.47%	0.44%

Characteristics

	IDNA	TMED
Management strategy	Passive	Active
Provider	iShares	T. Rowe Price
Benchmark	NYSE FactSet Global Genomics and Immuno Biopharma Index	-
N° of holdings	41	76
Asset class	Equities	-
Trailing 12m distribution yield	Join	Join
Inception date	June 11, 2019	June 11, 2025
ESG	No	No

More IDNA data on Trackinsight

More TMED data on Trackinsight

Exposure

Countries

IDNA

USA

63.25%

France

8.84%

Other

27.9%

TMED

USA

82.66%

Other

17.34%

Sectors

IDNA

Health Care

90.61%

Other

9.39%

TMED

Health Care

85.09%

Other

14.91%

Diversification

IDNA

Total weight of top 15 holdings out of 15

64.09%

TMED

Total weight of top 15 holdings out of 15

52.88%

Top 15 holdings

Data as of March 31, 2026

IDNA

MODERNA INC

6.75%

ARCELLX

5.36%

IPSEN PROMESSES

4.79%

TAKEDA PHARMACEUTICAL

4.62%

REVOLUTION MEDICINES INC

4.49%

MERCK & CO INC

4.44%

BAYER AG

4.31%

GSK PLC

4.16%

REGENERON PHARMACEUTICALS

3.96%

CH1499059983

3.72%

VERTEX PHARMACEUTICALS

3.61%

EXELIXIS

3.56%

SANOFI SA

3.54%

BIONTECH SE ADR

3.40%

INCYTE

3.38%

TMED

LILLY

14.48%

UNITEDHEALTH GRP

6.54%

THERMO FISHER SCIENTIFIC

4.59%

GILEAD SCIENCES

4.14%

ABBOTT LABS

3.91%

DANAHER

2.73%

MEDTRONIC PLC

2.24%

ALNYLAM PHARMACEUTICALS

2.06%

STRYKER

2.00%

DYNE THERAPEUTICS INC

1.88%

WATERS

1.75%

BECTON DICKINSON AND CO

1.71%

AGILENT TECHNOLOGIES

1.69%

ELANCO ANIMAL HEALTH INC

1.59%

HUMANA

1.57%

Frequently asked questions about IDNA and TMED

IDNAvsTMEDETF Comparison

iShares Genomics Immunology and Healthcare ETF

T. Rowe Price Health Care ETF

IDNA vs TMED performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the IDNA and TMED ETFs performed in 2026?

As of April 24, 2026, IDNA is up 14.46% year-to-date (YTD), while TMED has returned 0.34%. That puts IDNA better performer ahead so far this year.

Which ETF is attracting more investor money: IDNA or TMED?

Year-to-date, the IDNA ETF saw +$14M in flows, compared to +$3M for TMED.

Which ETF is bigger: IDNA or TMED?

As of April 24, 2026, IDNA holds $163.33 M in assets under management (AUM), while TMED manages $19.36 M.

What sectors do the IDNA and TMED ETFs invest in?

IDNA leans toward sectors like Health Care. Meanwhile, TMED focuses on Health Care.

What are the top holdings of the IDNA ETF and TMED ETF?

IDNA top holdings include MODERNA INC, ARCELLX and IPSEN PROMESSES. TMED holds in its top three: LILLY, UNITEDHEALTH GRP and THERMO FISHER SCIENTIFIC.

Which ETF is more diversified: IDNA or TMED?

IDNA holds 51 securities with 64.09% of its assets in the top 15. TMED has 82 securities and a top 15 weight of 52.88%.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up